Physician profile
Timothy William Bolek
NPI 1568460285
$1,572.02
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $164 · 2021: $227 · 2022: $138 · 2023: $218 · 2024: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Raysearch Laboratories Ab (Publ) | $485.00 | 2019 | |
| Boston Scientific Corporation | $386.74 | 2020-2024 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $147.09 | 2023-2024 | Orgovyx |
| Brainlab, INC. | $80.30 | 2019-2023 | Image Guided Surgical Device |
| Siemens Medical Solutions USA, INC. | $43.39 | 2023-2024 | Varian Ethos Treatment Planning, Bravos Afterloader System |
| Blue Earth Diagnostics | $42.87 | 2021 | |
| Palette Life Sciences, INC. | $42.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.64 | 2022-2023 | |
| Reflexion Medical, INC. | $41.53 | 2024 | Reflexion Medical Radiotherapy System |
| Dendreon Pharmaceuticals LLC | $41.48 | 2023 | Provenge |
| Elekta, INC. | $40.99 | 2019-2023 | Flexitron Hdr |
| Bayer Healthcare Pharmaceuticals INC. | $39.28 | 2019-2022 | |
| Profound Medical Corp. | $37.95 | 2023 | Tulsa-Pro |
| Varian Medical Systems, INC. | $34.48 | 2019-2020 | |
| Telix Pharmaceuticals | $19.96 | 2023 | Illuccix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $17.53 | 2021 | |
| Accuray Incorporated | $15.71 | 2022 | |
| Focal Therapeutics, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bolek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.